TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2025
Back to search
Official data from USPTO
EXELTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXELTIS
ST13
US500000079111421Class
5, 10, 35, 42
Filing
79111421
Registration
4594815
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
91
Latest update
09/24/2025
Trademark type
Word
Nice classes
5, 10, 35, 42
Filing date
03/05/2012
Registration date
09/02/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2024
Last transaction
09/24/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Barcelona, ES
Examiner
STRUCK, ROBERT
Current location
Historical data usage
Holders and representatives
Holders
CHEMO IBERICA, S.A.
CHEMO IBERICA, S.A.
Representatives
Vivian Ortiz-Ponce PEREZ GUERRERO LLC
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparation for use in treating * Pharmaceutical preparations for the treatment of ophthalmic diseases and disordersdermatological diseases and disorders* digestive diseases and disordergynecological diseases and disordershormonal diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseases* genitourinary disorders* immunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasespsychiatric diseasescentral nervous system* ; pharmaceutical preparations for the treatment of diseases of the * musculoskeletal system* diseases of the * respiratory systemcirculatory system* circulatory diseases* viral diseasesglaucomadental and oral * mouth * diseasesheadachesmigraineobesityhepatic treatments* treatment of the liver; * cholesterolblood pressure and rheumatic treatments; veterinary preparation for treating digestive diseases and disordergynecological diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasescentral nervous systemmusculoskeletal systemrespiratory systemcirculatory systemviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentscholesterolblood pressure and rheumatic treatments; and dietetic foods adapted for medical usebreadspastascrackerschipssnack foodspackaged mealsnutritional food barssweetsdipssauces and food supplements in pillpowdercapsulebeverage formeffervescent tablet and liquid form * ; none of the aforesaid products are preparations in connection with neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Class 10
Surgical apparatus and instruments; medical instruments for use in gynecological and respiratory disorders; *medical instruments for gynecological disordersophthalmic disordersdermatological disordersmetabolic and respiratory disorders; * orthopedic devices for diagnostic and therapeutic use; suture materials
Class 35
Sales promotion for third partiesbusiness management assistance; consulting on business management and marketing studies; presentation of goods on communication mediafor retail purposes; business administration of product licenses and services for others; organization of exhibitionstrade fairs or congresses for business or advertising purposesall relating to pharmaceuticalveterinary and biotechnological companies and for pharmaceuticalveterinary and biotechnological products *but none of the aforesaid goods relating to neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease or to goods in the field of neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Class 42
Chemicalbiological and pharmaceutical research services; engineering * all * none * the aforesaid goods relating to the field of neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Publications
History of USPTO decisions and trademark events.
91 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/05/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/07/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/07/2024
71AG
REGISTERED-SEC.71 ACCEPTED
08/07/2024
ES71
TEAS SECTION 71 RECEIVED
08/07/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/02/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/24/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/19/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/20/2021
INPC
INVALIDATION PROCESSED
08/20/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/09/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/09/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
12/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2020
ES71
TEAS SECTION 71 RECEIVED
09/02/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/02/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/14/2018
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/28/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/26/2017
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/26/2017
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
10/23/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/06/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/22/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/21/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/30/2017
INPC
INVALIDATION PROCESSED
03/30/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/11/2017
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
07/01/2016
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/01/2016
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/18/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/19/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/03/2014
FIMP
FINAL DISPOSITION PROCESSED
12/03/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2014
TMBN
TTAB RELEASE CASE TO TRADEMARKS
07/29/2014
OP.T
OPPOSITION TERMINATED NO. 999999
07/29/2014
OP.D
OPPOSITION DISMISSED NO. 999999
07/29/2014
RFNP
REFUSAL PROCESSED BY IB
06/20/2014
IRRF
IRREGULARITY ON REFUSAL FROM IB
05/19/2014
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
05/08/2014
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
05/06/2014
OP.I
OPPOSITION INSTITUTED NO. 999999
03/10/2014
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/24/2014
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/03/2013
GPNX
NOTIFICATION PROCESSED BY IB
11/13/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2013
PUBO
PUBLISHED FOR OPPOSITION
11/12/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/23/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/02/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/02/2013
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/02/2013
PBTQ
WITHDRAWN FROM PUB OTQR REQUEST
09/13/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/03/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/23/2013
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/22/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2013
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2013
ALIE
ASSIGNED TO LIE
07/23/2013
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/22/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/18/2013
GNRT
NON-FINAL ACTION E-MAILED
01/18/2013
CNRT
NON-FINAL ACTION WRITTEN
01/18/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/19/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/19/2012
RFNT
REFUSAL PROCESSED BY IB
07/07/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/20/2012
RFRR
REFUSAL PROCESSED BY MPU
06/20/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/20/2012
CNRT
NON-FINAL ACTION WRITTEN
06/19/2012
DOCK
ASSIGNED TO EXAMINER
06/14/2012
MAFR
APPLICATION FILING RECEIPT MAILED
05/01/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/26/2012
Continuous trademark protection
Get notified about every new filing that threatens EXELTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.